Clinical Trial Update: Stannsoporfin With Light Therapy for Newborn Babies With Jaundice [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating stannsoporfin with light therapy for neonatal jaundice has completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperbilirubinemia Neonatal
• Jaundice Neonatal

Drugs mentioned

• stannsoporfin (stannsoporfin)

Snippet

Sponsor: InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company | Conditions: Jaundice, Neonatal, Hyperbilirubinemia, Neonatal | Phase 2 | Status: COMPLETED | Results posted: 2019-11-13